22-Apr-2020 - Heinrich-Heine-Universität Düsseldorf

Artificial ‘candy canes’ block viruses

Synthetic glycomimetics attach to the viruses’ binding sites, which viruses normally use to attach to sugars on the cell surface

Synthetic chains of molecules containing different sugars can inhibit viruses effectively. The extent to which such molecules could be used as antiviral drugs is illustrated by a team of researchers from Heinrich Heine University Düsseldorf (HHU) and University of Münster (WWU) in the February edition of the Journal of the American Chemical Society.

Viruses are part of the human experience throughout our lives. They cause lots of different illnesses with the current coronavirus pandemic as just one example. While a vaccine does provide effective protection from viral infections, vaccines are only available for a select number of viruses. This is why antiviral drugs need to be found that can prevent or treat a viral infection.

One successful strategy involves special molecules to block viral proteins that would otherwise help the virus to attach to the host cell. Once a virus has attached to the cell surface, it can infect the cell with its genome and reprogram the cell for its own uses. However, many antiviral drugs lose their effect over time, as viruses mutate very quickly and thus often adapt to the medication/antiviral used.

The research team led by HHU Prof. Dr. Laura Hartmann from the Institute of Macromolecular Chemistry and Münster-based Prof. Dr. Mario Schelhaas from the Institute of Cellular Virology working together with Prof. Dr. Nicole Snyder from Davidson College in North Carolina, USA has used the approach of suppressing the initial contact between the virus and the cell in order to stop infection at the onset.

Viruses frequently use special proteins to bind to sugar molecules on the cell surface. Among others, these sugars include long-chain glycosaminoglycans (GAGs), which are strongly negatively charged. One of these GAGs is heparan sulfate. Researchers already knew that GAGs can reduce virus infections if they are added externally. However, natural polysaccharides may have side-effects that are attributed to their own biological function in the organism or to impurities.

The research team is now using the benefits of the GAGs but deactivates their disadvantages. The idea is to use molecules produced artificially and in a controlled fashion, so called ‘glycomimetics’, that are developed at HHU. They comprise a long synthetic scaffold with side chains with small sugar molecules attached. In Düsseldorf, both shorter chains with up to ten lateral sugars (known as ‘oligomers’) and long chains with up to 80 sugars (called ‘glycopolymers’) have been created. In order to simulate the highly charged state of natural GAGs, the chemists coupled sulfate groups to the sugars.

Prof. Schelhaas then used cell cultures to test the antiviral properties of these ‘candy canes’ of varying length at University Hospital Münster. Initially, his team used them against Human Papillomaviruses, which can trigger diseases such as cervical cancer. They discovered that both, the short and long-chain synthetic molecules, have an antiviral effect, but their mode of action is different. As expected, the more effective, long-chain molecules prevented the virus from attaching to cells. In contrast, the short-chain molecules displayed antiviral activity after attachment to the cell, giving rise to the assumption that these molecules are active in the organism for longer.

This is what Prof. Schelhaas has to say: “It is very likely that the long-chain molecules occupy the binding sites of the virus to the cell and thus block those sites. The short-chain molecules apparently do not block these sites. The next step is to test our hypothesis that these molecules prevent the redistribution of proteins in the virus particle so that the viruses cannot infect the cell.”

Effectiveness was also confirmed for the Papillomaviruses in an animal model. The compounds were also active against four other viruses, including Herpes viruses, which can cause cold sores and encephalitis, and Influenza viruses, which cause the flu. Prof. Hartmann explains: “Glycomimetics are thus promising compound molecules that could potentially be used in the fight against a large number of different viruses. The next thing to do is to examine the precise way in which the glycomimetics work and how they can be further optimised.”

Prof. Schelhaas adds: “Further research will focus on how fast viruses may adapt to this new class of compounds. With the short-chain molecules in particular, we are hopeful that viruses will find it harder to launch a counterattack.”

Facts, background information, dossiers

  • viruses
  • antiviral drugs
  • viral infection

More about Universität Düsseldorf

  • News

    Tiny sensors for major advances

    An international research team involving the working group of biophysicist Dr. Manuel Etzkorn from Heinrich Heine University Düsseldorf (HHU) has developed an approach for using NMR spectrometry to analyse important molecules that have not been accessible before now. In the journal Angewand ... more

    Release of Drugs from a Supramolecular Cage

    How can a highly effective drug be transported to the precise location in the body where it is needed? In the journal Angewandte Chemie, chemists at Heinrich Heine University Düsseldorf (HHU) together with colleagues in Aachen present a solution using a molecular cage that opens through ult ... more

    Research into Parkinson’s disease: binding-protein prevents fibril proliferation

    Several neurodegenerative diseases such as Parkinson’s are closely linked to the aggregation of a specific protein, α-synuclein. An international collaborative project involving Heinrich Heine University Düsseldorf (HHU), Forschungszentrum Jülich (FZJ) and RWTH Aachen University has now she ... more

  • q&more articles

    Surprisingly simple molecules as potential OLED-Emitters?

    Organic light emitting diodes (OLEDs) are presently conquering the market for displays of smartphones and TVs. They also have a great potential in lighting applications. Current devices for the blue part of the visible spectrum lag behind their green and red counterparts in terms of efficie ... more

  • Authors

    Kristoffer Thom

    Kristoffer Thom, born in 1993, studied chemistry at the Heinrich-Heine-University Düsseldorf, where he completed his bachelor thesis in the group of Rainer Weinkauf on mass spectrometry of peptides. For his master thesis he joined the group of Peter Gilch, investigating novel emitters for O ... more

    Prof. Dr. Peter Gilch

    Peter Gilch, born 1970, studied chemistry at the University of Konstanz before receiving his PhD in 1999 from the Technical University Munich. He then joined the Ludwig-Maximilians-University Munich for his Habilitation (2004) at the Lehrstuhl für BioMolekulare Optik. Since 2009 he has been ... more

More about WWU Münster

  • News

    Chemists succeed in synthesis of aminoalcohols by utilizing light

    Whether in beta-blockers to treat high blood pressure or in natural products: So-called vicinal aminoalcohols are high-quality organic compounds that are found in many everyday products. However, their production is difficult. For a long time, chemists are trying to develop efficient method ... more

    Understanding the progress of viral infections

    It is only 120 millionths of a millimetre in size but can bring entire countries to a standstill: the Corona virus. Even if it were to disappear one day, viral infections will still be among the most frequent and difficult-to-treat diseases in humans. Even decades of research have only prod ... more

    Watching changes in plant metabolism – live

    Almost all life on Earth, in particular our food and our health, depend on metabolism in plants. In order to understand how these metabolic processes function, researchers at the Institute of the Biology and Biotechnology of Plants at the University of Münster with the participation of the ... more

  • q&more articles

    Expressive

    Coupling biological molecules to surfaces, and using them in this form for measurement procedures, for analysis and in production processes, is a novel approach that is gaining increasing importance in industrial applications. Using established procedures, surfaces and biological molecules ... more

  • Authors

    Prof. Dr. Joachim Jose

    born 1961,studied biology at the University of Saarbrücken, where he was awarded a doctorate. He gained his professorship at the Institute of Pharmaceutical and Medicinal Chemistry of the University of the Saarland. From 2004 to 2011, he was professor for bioanalytics (C3) at the Heinrich-H ... more

q&more – the networking platform for quality excellence in lab and process

The q&more concept is to increase the visibility of recent research and innovative solutions, and support the exchange of knowledge. In the broad spectrum of subjects covered, the focus is on achieving maximum quality in highly innovative sectors. As a modern knowledge platform, q&more offers market participants one-of-a-kind networking opportunities. Cutting-edge research is presented by authors of international repute. Attractively presented in a high-quality context, and published in German and English, the original articles introduce new concepts and highlight unconventional solution strategies.

> more about q&more

q&more is supported by: